Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation

Transplantation

Volumn 97, Issue 5, 2014, Pages 525-533

  Leffell, Mary S ^a   Kim, Deborah ^b   Vega, Renato M ^a   Zachary, Andrea A ^a   Petersen, Jeffrey ^b   Hart, John M ^a   Rossert, Jerome ^b   Bradbury, Brian D ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

Calculated panel reactive antibody; Dialysis; HLA antibody; Kidney transplantation; Sensitization; Transfusion

Indexed keywords

HLA ANTIBODY;

ADULT; ALLOSENSITIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SENSITIZATION; SEX DIFFERENCE;

ADULT; AGED; ANTIBODIES; ANTIBODY FORMATION; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-OVER STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOASSAY; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; WAITING LISTS;

EID: 84896316162     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000437435.19980.8f     Document Type: Article

References (48)

1. Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 94
2. United States Renal Data System. USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Volume 2, Chapter 10. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012
3. Eschbach JW, Haley NR, Adamson JW. The anemia of chronic renal failure: Pathophysiology and effects of recombinant erythropoietin. Contrib Nephrol 1990; 78: 24; discussion 37
4. Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019
5. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085
6. Regidor D, McClellan WM, Kewalramani R, et al. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009. Nephrol Dial Transplant 2011; 26: 1583
7. Spiegel DM, Khan I, Krishnan M, et al. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008. Am J Kidney Dis 2010; 55: 113
8. Medicare Program: End-stage renal disease prospective payment system. Final rule. Federal Register 2010; 75: 49029
9. Brunelli SM,Monda KL, Burkart JM, et al. Early trends from the Study to Evaluate the Prospective Payment System impact on small dialysis organizations (STEPPS). Am J Kidney Dis 2013; 61: 947
10. Collins AJ. ESRD Payment Policy Changes: The New ''Bundled'' Dialysis Prospective Payment System (PPS) in the United States. 2012. Available from: Http://www.usrds.org/2012/pres/USDialysisBundle-impact-NKFCM2012.pdf. Accessed June 21, 2012
11. Locatelli F, Nissenson AR, Barrett BJ, et al. Clinical practice guidelines for anemia in chronic kidney disease: Problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2008; 74: 1237
12. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471
13. OpelzG,Graver B,MickeyMR, et al. Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 1981; 32: 177
14. Vella JP, O'Neill D, Atkins N, et al. Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplant 1998; 13: 2027
15. Grimm PC, Sinai-Trieman L, Sekiya NM, et al. Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity. Kidney Int 1990; 38: 12
16. Scornik JC, Meier-Kriesche HU. Blood transfusions in organ transplant patients: Mechanisms of sensitization and implications for prevention. Am J Transplant 2011;11: 1785
17. Macdougall IC, Obrador GT. How important is transfusion avoidance in 2013? Nephrol Dial Transplant 2013; 28: 1092
18. Zachary AA, Leffell MS. Detecting and monitoring human leukocyte antigen-specific antibodies. Human immunology 2008; 69: 591
19. Dausset J. [Indications for transfusion with concentrated or washed erythrocytes]. Concours Med 1954; 76: 2975
20. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799
21. Lagaaij EL, Hennemann IP, Ruigrok M, et al. Effect of one-HLA-DRantigen-matched and completely HLA-DRYmismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701
22. United States Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010
23. Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997; 63: 964
24. Vanrenterghem Y, Waer M, Roels L, et al. A prospective, randomized trial of pretransplant blood transfusions in cadaver kidney transplant candidates. Leuven Collaborative Group for Transplantation. Transplant Int 1994; 7: S243
25. Balasubramaniam GS, Morris M, Gupta A, et al. Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion. Transplantation 2012; 93: 418
26. Yabu JM, Anderson MW, Kim D, et al. Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrol Dial Transplant 2013; 28: 2908
27. Zachary AA, Sholander JT, Houp JA, et al. Using real data for a virtual crossmatch. Hum Immunol 2009; 70: 574
28. El-Awar N, Terasaki PI, Nguyen A, et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009; 70: 844
29. Zachary AA, Vega RM, Lucas DP, et al. HLA antibody detection and characterization by solid phase immunoassays: Methods and pitfalls. Methods Mol Biol 2012; 882: 289
30. Reed EF, Rao P, Zhang Z, et al. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant 2013; 13: 1859
31. Organ Procurement and Transplantation Network (OPTN). Proposal to Substantially Revise the National Kidney Allocation System. 2012. Available from: Http://optn.transplant.hrsa.gov/PublicComment/pubcomment PropSub-311.pdf. Accessed June 17, 2013
32. Network OPTN. Scientific Registry of Transplant Recipients: OPTN: Data. 2011. Available from: Http://optn.transplant.hrsa.gov/. Accessed September 2012
33. Ibrahim HN, Skeans MA, Li Q, et al. Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes. Clin Transplant 2011; 25: 653
34. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2011 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2012
35. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011
36. Scornik JC, Ireland JE, Howard RJ, et al. Assessment of the risk for broad sensitization by blood transfusions. Transplantation 1984; 37: 249
37. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825
38. Locke JE, Zachary AA, Warren DS, et al. Proinflammatory events are associated with significant increases in breadth and strength of HLAspecific antibody. Am J Transplant 2009; 9: 2136
39. Alberu J, Morales-Buenrostro LE, De Leo C, et al. A non-Allogeneic stimulus triggers the production of De novo HLA antibodies in healthy adults. Transplant Immunol 2007; 18: 166
40. Troidle L, Eisen T, Pacelli L, et al. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int 2007; 11: 72
41. KarpinskiM, Pochinco D, Dembinski I, et al. Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J Am Soc Nephrol 2004; 15: 818
42. Kliger AS, Foley RN, Goldfarb DS, et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis 2013; 62: 849
43. United States Renal Data System. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011
44. Gill KS, Muntner P, Lafayette RA, et al. Red blood cell transfusion use in patients with chronic kidney disease. Nephrol Dial Transplant 2013; 28: 1504
45. Food and Drug Administration Update on: Leukocyte Reduction of Blood and Blood Components Public Workshop. 2005. Available from: Http://www.fda.gov/ downloads/biologicsbloodvaccines/newsevents/ workshopsmeetingsconferences/ transcriptsminutes/ucm054436.pdf, 2013
46. Ibrahim HN, Ishani A, Foley RN, et al. Temporal trends in red blood transfusion among US dialysis patients, 1992-2005. Am J Kidney Dis 2008; 52: 1115
47. Cecka JM, Kucheryavaya AY, Reinsmoen NL, et al. Calculated PRA: Initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant 2011; 11: 719
48. Hebert PL, Geiss LS, Tierney EF, et al. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999; 14: 270